TAY THERAPEUTICS LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Tay Therapeutics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Tay Therapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
TAY THERAPEUTICS LIMITED is an active private limited company (company number SC651132) incorporated on 10 January 2020, registered in Dundee. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest abridged accounts cover the period ending 31 January 2026, showing net assets of £3.16m and cash of £1.68m, with 8 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public.
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
No active person with significant control is registered.
- Dr Christopher Andrew Woodland
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 10 January 20206 yrs ago
- Next accounts due
- 31 October 2027in 368 days
- Confirmation statement due
- 24 January 2027in 88 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2026 | £3.16m | £1.68m | £571k | £90k | — | — | 8 |
| 1 February 2025 | — | — | — | — | — | — | — |
| 31 January 2025 | £3.19m | £3.07m | £191k | £88k | — | — | 12 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £3,156,031 at 31 January 2026
- Current assets at least 1.5× creditors within one yearCurrent ratio 25.02
- Cash at bank of £50,000 or moreCash £1,684,712
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 10 January 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 368 days
- Confirmation statement duein 88 days
- Accounts period endNet assets £3.16m · abridged accounts
- Accounts period end
- Accounts period endNet assets £3.19m · abridged accounts
- Incorporated
Similar companies in Dundee
- OCCAM BIOSCIENCES LIMITEDDundee · inc. Aug 2021
- EYAM VACCINES AND IMMUNOTHERAPEUTICS UK LTDDundee · inc. Jan 2022
- VIEWBANK LEUCHARS LTDDundee · inc. Jul 2015
- TAY BIOSCIENCES LTDDundee · inc. Sept 2024
- MILONEX LTDDundee · inc. Sept 2014
- HAWKHILL THERAPEUTICS LIMITEDDundee · inc. Jun 2025
All companies incorporated on 10 January 2020 · in Jan 2020.
Reminders for TAY THERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.